We chat with James Sietstra, President of Seven Bridges, about the Cancer Genomics Cloud and enabling collaboration.
We chat with Genomics plc CEO John Colenutt about big data and what they’ll be up to Festival of Genomics
Answering your questions from Issue 4 of FLG Magazine
Marnie Gelbart of the Personal Genetics Education Project discusses how information can empower patients.
What better way to meet people outside of you area of expertise developing genomic new ideas, than by enjoying a nice cup of morning coffee overlooking the Pacific Ocean?
Ahead of Festival of Genomics in California, Dr Tom Fowler of Genomics England gave us valuable insight into how to manage a large-scale sequencing project
Ahead of the launch of Molecular Case Studies, Editor in Chief Elaine Mardis told us the story behind this new journal.
We talk pharmacogenomics with Jean-Claude Marshall of Pfizer: where the focus should be, next generation sequencing and the FDA’s draft guidance for LDTS.
What can the data wizards at Google do for genomics? Jonathan Bingham gives us some background the company and what they’re hoping to achieve.
Consultant physician and Imperial researcher Professor Eric Alton talks about the long road to developing effective gene therapy for cystic fibrosis.
A look at the remarkable experience that the Shenal family had with Greenwood Genetic Center, and how their relationship continues today.
We chat with Jacob Corn of Innovative Genomics Initiative about the genome editing boom.
Our interview with Alistair Kent OBE, Director of UK patient charity Genetic Alliance UK following the launch of their Patient Charter.
Our interview with David Smith of the Mayo Clinic, early adopter of next generation sequencing to understand cancer development.
We speak with Keith Bradnam about his career to date and his work as one of the premier genomic communicators.